Literature DB >> 3260960

Immunotherapy with Chinese medicinal herbs. I. Immune restoration of local xenogeneic graft-versus-host reaction in cancer patients by fractionated Astragalus membranaceus in vitro.

D T Chu1, W L Wong, G M Mavligit.   

Abstract

The in vitro immunomodulatory activity of fractions derived from Astragalus membranaceus, an herb commonly used in the practice of traditional Chinese medicine, was first screened by studying their individual effects on mononuclear cells (MNC) derived from healthy normal donors using the local xenogeneic graft-versus-host reaction (XGVHR). Sephacryl S-200 column-separated Fraction 3 (MW 20,000-25,000) along with its crude extract precursor, Fraction 7, and another crude extract derivative, Fraction 8, were equally augmentative (p less than 0.05) in their effect on MNC from normal donors. These three active fractions were further studied on MNC derived from 13 cancer patients. Using again the local XGVHR as a model assay for T-cell function, preincubation of MNC derived from cancer patients with Fraction 3 induced a significant increase in local XGVHR (compared to untreated cells) with a mean +/- SD of 151.34 +/- 46.02 mm3 vs 57.80 +/- 16.44 mm3; p less than 0.001. Fractions 7 and 8 likewise induced significant increases in local XGVHR (109.14 +/- 19.32 mm3 versus 50.91 +/- 17.39 mm3; p less than 0.001 and 119.74 +/- 18.33 mm3 versus 48.77 +/- 16.17 mm3; p less than 0.001, respectively). The augmented immune reactions which were induced by either Fraction 3 or Fraction 8 (but not by Fraction 7) in MNC derived from cancer patients, each significantly exceeded the local XGVHR observed in the untreated MNC derived from normal donor controls with a relative reference index (ratio) of 1.60 +/- 0.48 and 1.23 +/- 0.17 respectively; p less than 0.005.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260960

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  11 in total

1.  Astragalus-containing Chinese herbal combinations for advanced non-small-cell lung cancer: a meta-analysis of 65 clinical trials enrolling 4751 patients.

Authors:  Jean Jacques Dugoua; Ping Wu; Dugald Seely; Oghenowede Eyawo; Edward Mills
Journal:  Lung Cancer (Auckl)       Date:  2010-07-08

2.  Comparing the cytotoxic potential of Withania somnifera water and methanol extracts.

Authors:  Etheresia Pretorius; Hester Magdalena Oberholzer; Petrus Johannes Becker
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-05-07

3.  Suppressive effect of Chinese medicinal herb, Acanthopanax gracilistylus, extract on human lymphocytes in vitro.

Authors:  B E Shan; Y Yoshita; T Sugiura; U Yamashita
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  A survey on herbal management of hepatocellular carcinoma.

Authors:  Nabil Mohie Abdel-Hamid; Maiiada Hasan Nazmy; Ahmed Wahid Mahmoud; Michael Atef Fawzy; Marco Youssof
Journal:  World J Hepatol       Date:  2011-07-27

Review 5.  Herbs and other botanicals in cancer patient care.

Authors:  Barrie Cassileth; K Simon Yeung; Jyothirmai Gubili
Journal:  Curr Treat Options Oncol       Date:  2008-07-09

Review 6.  Evaluation of effectiveness of herbal medication in cancer care: a review study.

Authors:  Javad Tavakoli; Solaleh Miar; Mohammad Majid Zadehzare; Hossein Akbari
Journal:  Iran J Cancer Prev       Date:  2012

7.  Prediction of Radix Astragali Immunomodulatory Effect of CD80 Expression from Chromatograms by Quantitative Pattern-Activity Relationship.

Authors:  Michelle Chun-Har Ng; Tsui-Yan Lau; Kei Fan; Qing-Song Xu; Josiah Poon; Simon K Poon; Mary K Lam; Foo-Tim Chau; Daniel Man-Yuen Sze
Journal:  Biomed Res Int       Date:  2017-02-28       Impact factor: 3.411

8.  Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.

Authors:  Chin-Tsung Ting; Chian-Jue Kuo; Hsiao-Yun Hu; Ya-Ling Lee; Tung-Hu Tsai
Journal:  BMC Complement Altern Med       Date:  2017-02-20       Impact factor: 3.659

9.  Novel Diagnosis of Lyme Disease: Potential for CAM Intervention.

Authors:  Aristo Vojdani; Frank Hebroni; Yaniv Raphael; Jonathan Erde; Bernard Raxlen
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-15       Impact factor: 2.629

Review 10.  Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis.

Authors:  Ping Wu; Jean Jacques Dugoua; Oghenowede Eyawo; Edward J Mills
Journal:  J Exp Clin Cancer Res       Date:  2009-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.